A Phase 1 Parallel-Group, Double-Blind, Placebo-Controlled Cardiovascular and Behavioral Study Assessing Interactions Between Single Doses of Oral Reserpine and Intravenous Methamphetamine - 1

NCT00267657 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

30

Enrollment

NIH

Sponsor class

Conditions

Amphetamine-Related Disorders

Interventions

DRUG: Reserpine

Sponsor

National Institute on Drug Abuse (NIDA)